What is CYduct Diagnostics, Inc. (CYDX)?

CYduct Diagnostics, Inc. (CYDX) is a stock in the Healthcare sector, Medical - Devices industry. View full analysis on Stocks360.

What is the current price of CYDX?

The current price of CYDX is $0.50. Prices are updated in real time on Stocks360.

What is CYDX's price-to-earnings (PE) ratio?

CYDX's trailing twelve-month PE ratio is -11.14, based on current price and earnings per share data available on Stocks360.

What is CYDX's market capitalization?

CYDX's market capitalization is $6,391,582.00, placing it in the small-cap tier.

CYduct Diagnostics, Inc. (CYDX)

Stock analysis · OTC · Healthcare · Medical - Devices

$0.50

Market Cap

$6.39M

PE (TTM)

-11.14

EPS (TTM)

N/A

Dividend Yield

0.00%

Beta

-0.93

Day Range

$0.30 – $0.50

52-wk Range

$0.20 – $2.90

Avg Volume

N/A

Volume

1.00

CYduct Diagnostics, Inc. (CYDX) is a publicly traded company in the Healthcare sector. Latest price: $0.50. Market cap $6.39M. Trailing PE -11.14. Sign in to Stocks360 for full DCF valuation, fundamentals, technicals, and AI-driven analysis.

Get full analysis → Short-Term Analysis →

1-Year Price

2025-10-29 · $0.20 2026-10-26 · $0.50 (+146.18%)

Proprietary Signals

Signal snapshot temporarily unavailable.

About CYduct Diagnostics, Inc.

CYduct Diagnostics, Inc. operates as a medical instrument enterprise that engineers and commercializes a diverse range of technologies, equipment, and methodologies. These innovations are purposed for the detection, diagnosis, therapeutic intervention, and general management of various health conditions and illnesses. The company's extensive product offerings include specialized breast endoscopy systems, an assortment of camera solutions (such as 3-chip and 1-chip models), and all necessary accessories. They also provide a broad selection of endoscopic instruments, encompassing surgical tools like dissectors, graspers, scissors, needle holders, fan retractors, cautery devices, and insufflation needles. Furthermore, CYduct supplies illumination series products, including fiber optic cables, light port adapters, light sources, and replacement lamps, alongside insufflators. For surgical specialties, their portfolio features laparoscopic instruments designed for general surgery, lymphadenectomy, gynecology, and thorascopy. Complementing these are rigid scopes (like laparoscopes, operative scopes, and cystoscopes) with their corresponding accessories, as well as trocar and cannula sets…

Valuation

Trailing twelve months. Multiples relative to current market price.
P/E (TTM)	-11.14×
P/S (TTM)	90.83×
P/B	-6.06×
P/FCF (TTM)	556.27×
EV / EBITDA	-45.79×
EV / Sales	100.78×
Earnings Yield	-3.24%
Free Cash Flow Yield	0.18%

Fundamentals

Trailing twelve months. Source: financial statements via market data.
Enterprise Value	$7.09M
Revenue (TTM)	$70.37K
Net Income (TTM)	-$207.40K
Free Cash Flow (TTM)	$64.01K
Net Debt	$700.68K
Working Capital	-$427.18K
Gross Margin	62.32%
Operating Margin	-220.10%
Net Margin	-294.73%
Return on Equity	8.29%
Return on Invested Capital	44.61%